{"schema_version":"1","generated_at":"2026-10-29T06:59:52.333Z","data_as_of":null,"url":"https://www.findmykol.com/kol/gilbert-youssef","json_url":"https://www.findmykol.com/kol/gilbert-youssef/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"gilbert-youssef","name":"Gilbert Youssef","credential":"MD","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"institution":"Harvard University","institution_url":"https://www.findmykol.com/institution/harvard-university","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1891250981","orcid":"0000-0001-6109-7692","openalex":"A5025462204"},"summary":"Gilbert Youssef is a Neurology physician affiliated with Harvard University. OpenAlex indexes 110 publications with 1,232 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Neurology"]},"scholarship":{"works_count":110,"cited_by_count":1232,"h_index":14,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07075627","title":"A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)","status":"WITHDRAWN","role":"Overall official","sponsor":"Addario Lung Cancer Medical Institute","source_url":"https://clinicaltrials.gov/study/NCT07075627","trial_url":"https://www.findmykol.com/trial/NCT07075627"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"SERVIER PHARMACEUTICALS LLC","program_year":2025,"amount_usd":124.99,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1891250981"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1891250981","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Sensory organs","share_pct":38.6,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":38.6,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":16}]},{"area":"Metabolism & gastrointestinal","share_pct":35.1,"classes_total":1,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":35.1,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":11}]},{"area":"Anti-infectives","share_pct":26.3,"classes_total":1,"classes":[{"class":"Short-acting sulfonamides","setting":"prescribed","share_pct":26.3,"drugs":[{"name":"Sulfamethoxazole-Trimethoprim","share_pct":100}],"max_beneficiaries":12}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":18.5,"facility_pct":81.5},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group","year":2025,"journal":"The Lancet Oncology","source_url":"https://doi.org/10.1016/s1470-2045(25)00534-0","status":"verified"},{"title":"Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4","year":2025,"journal":"Neuro-Oncology","source_url":"https://doi.org/10.1093/neuonc/noaf133","status":"verified"},{"title":"The use of minor response, volumetric assessment, and growth rate kinetics as endpoints in grade 1-3 glioma clinical trials: a RANO perspective","year":2025,"journal":"Neuro-Oncology","source_url":"https://doi.org/10.1093/neuonc/noaf173","status":"verified"},{"title":"Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.24.00953","status":"verified"},{"title":"A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: A report by the RANO resect group.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.2001","status":"verified"}],"source":"works"},"contact":{"address_1":"450 BROOKLINE AVE","city":"Boston","state":"MA","zip":"022155450","phone":"617-632-2166","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1891250981","source":"identity"},"similar":[{"name":"Felipe Fregni","slug":"felipe-fregni","institution":"Harvard University","specialty":"Neurology","url":"https://www.findmykol.com/kol/felipe-fregni","json_url":"https://www.findmykol.com/kol/felipe-fregni/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Sarah Fortune","slug":"sarah-fortune","institution":"Harvard University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/sarah-fortune","json_url":"https://www.findmykol.com/kol/sarah-fortune/profile.json"},{"name":"Ethan Lerner","slug":"ethan-lerner","institution":"Harvard University","specialty":"Dermatology","url":"https://www.findmykol.com/kol/ethan-lerner","json_url":"https://www.findmykol.com/kol/ethan-lerner/profile.json"},{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-03-06","provider_certified":"2023-03-06","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}